-
Experts suggest speedy trial and application of HAS in NCP
Experts suggest speedy trial and application of superantigen Gaojusheng Jinpushu （known as HAS）in novel coronavirus patients （NCP）多名专家学者建议尽快试用推广超抗原金葡素治疗新冠病毒患者Recently, China has started the urgent cli
2023-12-14 213
-
Inhibition of p300 impairs Foxp3+ T regulatory cell function
AbstractForkhead box P3 (Foxp3)+ T regulatory (Treg) cells maintain immune homeostasis and limit autoimmunity but can also curtail host immune responses to various types of tumors1,2. Foxp3+
2023-08-10 155
-
Zanu-PF MP, China launch partnership
Kuwadzana MP Betty Kaseke (Zanu PF), through a foundation named after her, on Monday signed a memorandum of understanding with World Friends Day of China that will see the former provide life-saving d
2017-09-19 352
-
Shenyang Xiehe Group get a great achievement in bio-medical
May 11th 2007, an academic forum named “Chinese Intellectual Property Right- Superantigen Scientific and Technological Achievements Signing Ceremony of International Cooperation Items” was hold in the
2007-05-12 361